Fine lines caused by repeated facial expressions can become more noticeable with time, especially around the forehead, between the eyebrows, and around the eyes. Neurotoxin injections offer a nonsurgical way to temporarily soften these expression lines while maintaining a natural appearance when treatment is appropriately planned.
But Botox® is no longer the only name patients encounter.
Today, patients considering neurotoxin treatments in Omaha may have several options, including Botox®, Xeomin®, and Letybo®. While all three contain forms of botulinum toxin type A and work by temporarily reducing targeted muscle activity, there are differences in their formulations, FDA approved indications, and histories in the U.S. market. Understanding these differences is crucial in choosing among the best neurotoxins Omaha has to offer.
At Functional Healthcare of Omaha, Letybo® and Xeomin® are available as neurotoxin options. So how do they compare with Botox®, the brand that has become almost synonymous with wrinkle relaxing injections?
This guide explores Letybo vs Xeomin vs Botox, including how neurotoxins work, what makes each product different, what treatment can accomplish, and what patients should consider when choosing a neurotoxin.
For those seeking the best options in neurotoxins Omaha, it’s essential to consult with a qualified provider who can guide you based on your unique needs.
Exploring Neurotoxins Omaha
What Are Neurotoxins?
In aesthetic medicine, neurotoxins are injectable medications containing botulinum toxin type A. They are commonly used to temporarily improve certain facial lines associated with muscle movement.
When you smile, squint, concentrate, or raise your eyebrows, facial muscles contract. The skin above those muscles repeatedly folds in similar locations. Over time, these dynamic lines can become increasingly visible.
Neurotoxins work at the neuromuscular junction by temporarily reducing the release of acetylcholine, a chemical messenger involved in muscle contraction. When carefully injected into selected muscles, the targeted muscle activity decreases.
The result can be smoother looking skin and less noticeable expression lines.
Neurotoxins do not add volume like dermal fillers. Instead, they address the muscular movement contributing to dynamic wrinkles.
What Areas Can Neurotoxins Treat?
Depending on the product, treatment plan, and approved or clinically appropriate use, neurotoxins may be considered for areas such as:
- Frown lines between the eyebrows
- Forehead lines
- Crow’s feet around the eyes
- Other areas involving facial muscle activity, when appropriate
The exact treatment areas depend on the patient’s anatomy, goals, medical history, product labeling, and provider’s clinical assessment.
This distinction is important because Botox, Xeomin, and Letybo do not have identical FDA approved cosmetic indications in the United States.
Letybo vs Xeomin vs Botox: Quick Comparison
All three products are botulinum toxin type A formulations, but they are distinct prescription medications and should not be treated as interchangeable.
| Letybo® | Xeomin® | Botox® Cosmetic | |
|---|---|---|---|
| Active toxin | LetibotulinumtoxinA | IncobotulinumtoxinA | OnabotulinumtoxinA |
| Type | Botulinum toxin type A | Botulinum toxin type A | Botulinum toxin type A |
| Manufacturer | Hugel | Merz Aesthetics | Allergan Aesthetics, an AbbVie company |
| U.S. cosmetic history | Newer U.S. option | Established option | Long established option |
| Notable formulation characteristic | Proprietary formulation | Purified to remove accessory proteins | Contains accessory proteins |
| FDA cosmetic indications | Glabellar lines | Glabellar lines | Multiple approved facial areas |
| Available at Functional Healthcare of Omaha | Yes | Yes | Check with clinic |
Most importantly, the units used for one botulinum toxin product cannot simply be converted into equivalent units of another product. Each has its own formulation, dosing, and prescribing information.
Neurotoxins Omaha: Understanding Your Options
What Is Letybo®?
Letybo is the brand name for letibotulinumtoxinA-wlbg, a botulinum toxin type A injectable.
While Letybo may be newer to many American patients, the product has an international history. The FDA approved Letybo in 2024 for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adults.
Glabellar lines are the vertical lines that develop between the eyebrows, often called “11 lines.”
Letybo gives patients and providers another FDA approved option for treating these lines.
The FDA prescribing information provides detailed information about Letybo’s approved indication, dosing, contraindications, warnings, and clinical trial data. FDA Letybo Prescribing Information
Why Might Someone Consider Letybo?
A patient might choose Letybo because their provider believes it fits their anatomy, goals, previous treatment experience, or desired treatment plan.
Rather than asking whether Letybo is universally “better” than another neurotoxin, the more useful question is whether it is appropriate for the individual patient and treatment area.
What Is Xeomin®?
Xeomin is the brand name for incobotulinumtoxinA.
One of its best known characteristics is its manufacturing process. Xeomin contains the active neurotoxin without the accessory proteins found in some other botulinum toxin formulations.
This has led to the nickname “naked neurotoxin,” although that term is more useful for marketing than for understanding clinical outcomes.
The important point is that Xeomin has a different formulation from Botox.
For cosmetic use, Xeomin is FDA approved for the temporary improvement in the appearance of moderate to severe glabellar lines in adults.
Patients can review the official product information from Xeomin.
Why Might Someone Consider Xeomin?
Xeomin may be considered for patients looking for an established botulinum toxin type A option, including those whose provider prefers its formulation for their treatment plan.
The absence of accessory proteins is a meaningful formulation difference, but patients should be cautious about claims suggesting that this automatically makes Xeomin safer, more effective, or less likely to cause treatment resistance for every cosmetic patient.
Individual response matters.
What Is Botox® Cosmetic?
Botox Cosmetic contains onabotulinumtoxinA and is arguably the most recognized cosmetic neurotoxin brand in the United States.
Botox has a long history in both medical and aesthetic applications.
For cosmetic purposes, Botox Cosmetic has FDA approved indications for the temporary improvement of moderate to severe:
- Glabellar lines
- Lateral canthal lines, commonly called crow’s feet
- Forehead lines
- Platysma bands
The number of approved treatment areas is one of the most notable differences when comparing Botox with Letybo and Xeomin.
Patients can find current product and safety information through Botox Cosmetic.
Is Xeomin Better Than Botox?
Xeomin and Botox are both established neurotoxins, but their formulations differ.
Xeomin’s active neurotoxin is manufactured without accessory proteins, while Botox’s formulation includes the active neurotoxin as part of a protein complex.
You may see claims online that Xeomin’s formulation means patients cannot develop resistance to it. That oversimplifies the evidence.
Neutralizing antibodies and reduced treatment response are complex topics. Product formulation may be one consideration, but treatment dose, frequency, individual biology, and other factors may also matter.
For most aesthetic patients, the practical question is:
Which product gives me a safe, natural result for the area I want treated?
That is best determined through consultation rather than brand reputation alone.
Does Letybo Last Longer Than Botox or Xeomin?
Patients naturally want to know which neurotoxin lasts longest.
There is no simple answer that applies to everyone.
The duration of a neurotoxin result can vary based on:
- Product used
- Dose
- Treatment area
- Muscle strength
- Individual metabolism
- Treatment history
- Injection technique
For many botulinum toxin aesthetic treatments, results are temporary and commonly last several months.
Rather than selecting a product based solely on claims that one “lasts longer,” patients should discuss expected duration for their specific treatment with their provider.
Direct comparisons can also be difficult because Botox, Xeomin, and Letybo use product specific units.
Understanding Neurotoxin Units
This is particularly important when comparing prices.
If one clinic advertises a lower price “per unit” for one neurotoxin than another clinic charges for a different product, the numbers do not necessarily represent equivalent treatment.
According to botulinum toxin prescribing information, potency units are specific to each preparation.
In other words:
20 units of one brand should not automatically be assumed to equal 20 units of another brand clinically.
Comparing neurotoxins solely by per unit pricing can therefore be misleading.
Patients should consider the complete treatment plan, including the product, treatment area, recommended dose, provider expertise, and expected outcome.
Letybo vs Xeomin: What Is the Difference?
For patients at Functional Healthcare of Omaha, this may be the most relevant comparison because the clinic offers both products.
Letybo
Letybo is a newer U.S. aesthetic option containing letibotulinumtoxinA-wlbg. It is FDA approved for moderate to severe glabellar lines in adults.
Xeomin
Xeomin contains incobotulinumtoxinA and is also FDA approved for moderate to severe glabellar lines. Its formulation does not contain the accessory proteins found in certain other botulinum toxin products.
What They Have in Common
Both:
- Are botulinum toxin type A medications
- Temporarily reduce targeted muscle activity
- Are FDA approved for glabellar lines
- Require professional administration
- Produce temporary results
- Carry important contraindications and safety warnings
For many patients, choosing between them will depend less on which brand is “best” and more on which product the provider recommends for their specific needs.
What Results Should You Expect From a Neurotoxin Treatment?
Neurotoxin results are not typically immediate.
After treatment, the targeted muscle activity gradually decreases, allowing dynamic wrinkles to become less noticeable.
The goal does not have to be a frozen appearance.
Modern aesthetic treatment can be customized based on the patient’s anatomy and desired level of movement.
Some patients want significant softening of expression lines. Others want a subtle result that preserves more facial movement.
Your provider can adjust the treatment plan accordingly.
What Happens During a Neurotoxin Appointment?
A neurotoxin treatment generally begins with an aesthetic consultation.
Your provider may assess:
- Facial symmetry
- Muscle strength
- Existing expression lines
- How your face moves
- Previous injectable treatments
- Desired outcome
You may be asked to smile, frown, squint, or raise your eyebrows so the provider can evaluate muscle movement.
The injections themselves are administered using a small needle at carefully selected points.
Treatment is generally quick, although appointment time varies depending on the consultation and number of areas treated.
Is There Downtime After Letybo or Xeomin?
Neurotoxin injections generally involve minimal downtime.
Patients may experience temporary effects around the injection sites, such as:
- Redness
- Swelling
- Tenderness
- Bruising
Other adverse effects can occur, and each product carries prescribing information and safety warnings that should be reviewed with a qualified healthcare professional.
Patients should follow their provider’s aftercare instructions.
Are Neurotoxins Safe?
Botulinum toxin products have been extensively studied, but they are prescription medications and carry potential risks.
All botulinum toxin products include a boxed warning regarding the possibility of effects spreading beyond the injection site. Serious effects can include swallowing or breathing difficulties, although the risks vary depending on treatment circumstances.
Patients should tell their provider about:
- Medical conditions
- Neuromuscular disorders
- Previous botulinum toxin treatments
- Prescription medications
- Supplements
- Pregnancy or plans for pregnancy
- Breastfeeding
- Allergies
The FDA provides additional information about botulinum toxin products and medication safety through its Drug Safety and Availability resources.
Can You Switch From Botox to Letybo or Xeomin?
Having previously received Botox does not necessarily mean you must continue using the same brand indefinitely.
A provider may determine that another botulinum toxin product is appropriate at a future treatment.
However, your provider should know:
- Which product you previously received
- When you received it
- Which areas were treated
- Your approximate dose, if known
- How you responded
- How long the result lasted
- Whether you experienced side effects
Do not schedule overlapping neurotoxin treatments without discussing your recent injection history with your provider.
What About Preventative Neurotoxins?
Younger adults sometimes consider neurotoxins before deep expression lines become visible at rest.
The concept is commonly called “preventative Botox,” although the strategy can involve other neurotoxin brands as appropriate.
The reasoning is straightforward. Dynamic wrinkles are repeatedly created by muscle movement. Reducing selected muscle activity may reduce repeated folding of the overlying skin.
However, age alone should not determine whether someone needs neurotoxin treatment.
A qualified provider should consider facial anatomy, muscle activity, existing lines, goals, and whether treatment is appropriate.
Neurotoxins vs Dermal Fillers
Neurotoxins and dermal fillers are both injectables, but they serve different purposes.
Neurotoxins primarily reduce targeted muscle activity.
Dermal fillers add volume or structural support.
For example, a dynamic forehead line caused primarily by repeated muscle movement may be addressed with a neurotoxin. Volume loss in areas such as the cheeks may require an entirely different approach.
Some patients benefit from combining treatments, but only after an individualized assessment.
Choosing a Neurotoxin Provider in Omaha
When researching neurotoxins in Omaha, the injector matters as much as the brand.
Facial anatomy is complex. A successful treatment requires understanding how different muscles interact and how changing one area may affect another.
Look for a clinic that:
- Conducts an individual consultation
- Reviews your medical and injectable history
- Explains the product being used
- Discusses realistic outcomes
- Provides clear aftercare instructions
- Prioritizes natural looking results
- Uses authentic prescription products
A provider should also be willing to explain why they recommend a specific neurotoxin rather than simply choosing based on trends.
Letybo and Xeomin at Functional Healthcare of Omaha
At Functional Healthcare of Omaha, patients interested in reducing expression lines can discuss neurotoxin treatment with the clinical team and determine whether Letybo or Xeomin may be appropriate for their goals.
Treatment begins with understanding your facial anatomy and desired outcome.
For some patients, that may mean softening prominent frown lines. Others may want a refreshed appearance while retaining natural facial expression.
The objective is not to make every patient’s face look the same. It is to develop a treatment plan appropriate for the individual.
For patients who have previously received Botox, a consultation also provides an opportunity to discuss whether Letybo or Xeomin could be considered for future treatments.
Frequently Asked Questions About Letybo, Xeomin, and Botox
Is Letybo the same as Botox?
No. Both are botulinum toxin type A products, but Letybo contains letibotulinumtoxinA-wlbg while Botox contains onabotulinumtoxinA. They have separate formulations and prescribing information.
Is Xeomin the same as Botox?
No. Xeomin contains incobotulinumtoxinA. It is manufactured without accessory proteins, which differentiates its formulation from Botox.
Is Letybo FDA approved?
Yes. Letybo received FDA approval in 2024 for the temporary improvement of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adults.
Which lasts longer, Botox, Xeomin, or Letybo?
Duration varies between patients and depends on factors including dose, treatment area, muscle activity, metabolism, and product. Your provider can give you a more individualized expectation.
Which neurotoxin looks the most natural?
Natural looking results depend heavily on assessment, dosing, injection placement, facial anatomy, and the desired result. There is not one brand that automatically creates a more natural result for every patient.
Can I get Letybo if I’ve had Botox before?
Potentially. Previous Botox treatment does not automatically prevent someone from receiving another botulinum toxin product later. Your provider should review your treatment history first.
Is Xeomin better because it has no accessory proteins?
Xeomin’s purified formulation is one of its distinguishing characteristics, but that alone does not make it the best option for every patient. Product selection should be individualized.
Your Experience Begins with a
Get to Know You Consultation
Before any treatment begins, we take the time to truly understand you. Your Get to Know You Consultation includes a personalized evaluation, expert guidance, and a customized plan designed just for you. This is where your transformation begins—with trust, clarity, and care.
